13-39679963-AT-ATT

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 2P and 16B. PVS1_ModerateBP6_Very_StrongBA1

The NM_020751.3(COG6):​c.624-3dupT variant causes a splice acceptor, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.236 in 1,389,362 control chromosomes in the GnomAD database, including 35,440 homozygotes. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.27 ( 5858 hom., cov: 21)
Exomes 𝑓: 0.23 ( 29582 hom. )

Consequence

COG6
NM_020751.3 splice_acceptor, intron

Scores

Not classified

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.428

Publications

2 publications found
Variant links:
Genes affected
COG6 (HGNC:18621): (component of oligomeric golgi complex 6) This gene encodes a subunit of the conserved oligomeric Golgi complex that is required for maintaining normal structure and activity of the Golgi apparatus. The encoded protein is organized with conserved oligomeric Golgi complex components 5, 7 and 8 into a sub-complex referred to as lobe B. Alternative splicing results in multiple transcript variants.[provided by RefSeq, Feb 2009]
COG6 Gene-Disease associations (from GenCC):
  • COG6-congenital disorder of glycosylation
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: PanelApp Australia, Orphanet, Labcorp Genetics (formerly Invitae)
  • hypohidrosis-enamel hypoplasia-palmoplantar keratoderma-intellectual disability syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

PVS1
Splicing +-2 bp (donor or acceptor) variant, product NOT destroyed by NMD, known LOF gene, truncates exone, which is 0.035967577 fraction of the gene. Cryptic splice site detected, with MaxEntScore 7.4, offset of 0 (no position change), new splice context is: atcattaattttttttttAGttt. Cryptic site results in inframe change. If cryptic site found is not functional and variant results in exon loss, it results in frameshift change.
BP6
Variant 13-39679963-A-AT is Benign according to our data. Variant chr13-39679963-A-AT is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 198581.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.357 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_020751.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
COG6
NM_020751.3
MANE Select
c.624-3dupT
splice_acceptor intron
N/ANP_065802.1
COG6
NM_001145079.2
c.624-3dupT
splice_acceptor intron
N/ANP_001138551.1
COG6
NR_026745.1
n.789-3dupT
splice_acceptor intron
N/A

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
COG6
ENST00000455146.8
TSL:1 MANE Select
c.624-3dupT
splice_acceptor intron
N/AENSP00000397441.2
COG6
ENST00000416691.6
TSL:1
c.624-3dupT
splice_acceptor intron
N/AENSP00000403733.1
COG6
ENST00000356576.8
TSL:1
n.*461-3dupT
splice_acceptor intron
N/AENSP00000348983.4

Frequencies

GnomAD3 genomes
AF:
0.274
AC:
41422
AN:
151418
Hom.:
5851
Cov.:
21
show subpopulations
Gnomad AFR
AF:
0.362
Gnomad AMI
AF:
0.193
Gnomad AMR
AF:
0.186
Gnomad ASJ
AF:
0.192
Gnomad EAS
AF:
0.280
Gnomad SAS
AF:
0.264
Gnomad FIN
AF:
0.278
Gnomad MID
AF:
0.241
Gnomad NFE
AF:
0.245
Gnomad OTH
AF:
0.267
GnomAD2 exomes
AF:
0.240
AC:
55295
AN:
230006
AF XY:
0.242
show subpopulations
Gnomad AFR exome
AF:
0.361
Gnomad AMR exome
AF:
0.151
Gnomad ASJ exome
AF:
0.190
Gnomad EAS exome
AF:
0.289
Gnomad FIN exome
AF:
0.278
Gnomad NFE exome
AF:
0.241
Gnomad OTH exome
AF:
0.224
GnomAD4 exome
AF:
0.231
AC:
285939
AN:
1237828
Hom.:
29582
Cov.:
20
AF XY:
0.232
AC XY:
144852
AN XY:
625694
show subpopulations
African (AFR)
AF:
0.341
AC:
9605
AN:
28162
American (AMR)
AF:
0.146
AC:
6340
AN:
43486
Ashkenazi Jewish (ASJ)
AF:
0.186
AC:
4570
AN:
24552
East Asian (EAS)
AF:
0.287
AC:
10823
AN:
37726
South Asian (SAS)
AF:
0.233
AC:
18233
AN:
78230
European-Finnish (FIN)
AF:
0.271
AC:
14184
AN:
52414
Middle Eastern (MID)
AF:
0.203
AC:
1048
AN:
5158
European-Non Finnish (NFE)
AF:
0.228
AC:
208974
AN:
915626
Other (OTH)
AF:
0.232
AC:
12162
AN:
52474
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
9636
19272
28907
38543
48179
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
6800
13600
20400
27200
34000
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.274
AC:
41454
AN:
151534
Hom.:
5858
Cov.:
21
AF XY:
0.274
AC XY:
20261
AN XY:
74040
show subpopulations
African (AFR)
AF:
0.362
AC:
14979
AN:
41354
American (AMR)
AF:
0.185
AC:
2820
AN:
15222
Ashkenazi Jewish (ASJ)
AF:
0.192
AC:
667
AN:
3466
East Asian (EAS)
AF:
0.280
AC:
1444
AN:
5160
South Asian (SAS)
AF:
0.263
AC:
1263
AN:
4808
European-Finnish (FIN)
AF:
0.278
AC:
2900
AN:
10436
Middle Eastern (MID)
AF:
0.228
AC:
67
AN:
294
European-Non Finnish (NFE)
AF:
0.245
AC:
16582
AN:
67784
Other (OTH)
AF:
0.265
AC:
557
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1485
2969
4454
5938
7423
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
426
852
1278
1704
2130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.146
Hom.:
308
Bravo
AF:
0.267
Asia WGS
AF:
0.278
AC:
955
AN:
3432

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Jun 12, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency

Congenital disorder of glycosylation Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:1
Jul 21, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

COG6-congenital disorder of glycosylation;C3809160:Hypohidrosis-enamel hypoplasia-palmoplantar keratoderma-intellectual disability syndrome Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
PhyloP100
-0.43
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs397756552; hg19: chr13-40254100; API